number share
result beat analyst estim term top
compani report revenu bln repres
increas y/i
adjust non-gaap earn
adjust dilut earn per share ep period
bln respect bottom-lin result repres
increas respect compar
period
revenu compani core segment pharmaceut
gener almost total revenu climb
y/i bln oper margin adjust
measur came y/i segment strong
perform primarili reflect boost sale cancer drug
sale medic devic account total revenu
rose y/i bln segment oper margin
reduc y/i compani manag increas
sale surgeri y/i vision y/i product
consum segment revenu edg y/i bln
oper margin improv
segment result driven higher sale over-the-count
y/i beauti y/i product off-set
lower sale babi care product y/i
compani also lower revenu guidanc fy
bln y/i bln narrow
adjust ep guidanc fy
y/i
updat valuat analysi stock reflect
market movement peer compani financi
forecast compani updat follow earn
report guidanc cut
valuat reveal compani trade discount peer
median base ev/ebitda price-to-book premium
base price-to-earnings
final fair valuat compani share perform upon
three multipl ev/ebitda price-to-earnings price-to-book weight
multipl taken equal
 consensu estim thomson reuter
co
premium/ discount median
thomson reuter data/finviz avail
multipl
accord estim per-shar target price
compar previou updat
april impli upsid current price
thu reiter stock rate neutral
terminolog use report
 market capit calcul multipli compani share outstand current market price one share
 net debt metric show compani overal debt situat net valu compani liabil debt cash
similar liquid asset
 enterpris valu ev measur compani total valu calcul market capit plu debt minor
interest prefer share minu total cash cash equival
 price-to-earnings price-to-earn compar price earn per share compani one analyz market stock valuat
compani share rel incom compani actual gener
 ev/ebitda enterpris value-to-earn interest tax depreci amort metric estim
busi valuat compar valu compani inclus debt liabil actual cash earn exclus
non-cash expens
 ev/ enterpris valu -to -sale valuat measur compar enterpris valu compani compani sale ev/
give investor idea much cost buy compani sale
 price-to-book price-to-book valu ratio use compar stock market valu book valu calcul divid current
close price stock latest quarter book valu per share
 p/ price-to-sal ratio show much marketvalu everi dollar compani sale calcul divid
compani market cap revenu recent year
 dp dividend per share repres dividend paid per share primari common sharehold
 div yield dividend yield financi ratio indic much compani pay dividend year rel share
teletrad rank stock accord estim upsid /downsid potenti follow
stock rate fair price assign due unavail suffici data design rate
teletrad put stock review price target and/or recommend subject chang base latest financi result
newli arisen risk factor import event teletrad make reason effort reinstat recommend price target
stock review shortest possibl time
